Abbott Laboratories - 36 Year Stock Price History | ABT

Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits. The latest closing stock price for Abbott Laboratories as of December 09, 2019 is 83.87.
  • The all-time high Abbott Laboratories stock closing price was 88.74 on July 23, 2019.
  • The Abbott Laboratories 52-week high stock price is 88.76, which is 5.8% above the current share price.
  • The Abbott Laboratories 52-week low stock price is 65.44, which is 22% below the current share price.
  • The average Abbott Laboratories stock price for the last 52 weeks is 79.62.
Abbott Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 80.1556 69.5000 88.7400 66.2200 83.8700 15.95%
2018 64.2198 58.7900 74.2700 56.2700 72.3300 26.74%
2017 48.5437 39.0500 57.4700 39.0500 57.0700 48.58%
2016 40.4946 42.9300 45.2900 36.3400 38.4100 -14.47%
2015 46.3063 44.9000 51.2000 39.0600 44.9100 -0.24%
2014 40.9592 38.2300 46.3700 35.8500 45.0200 17.45%
2013 35.6540 32.0500 38.7100 32.0500 38.3300 -41.48%
2012 62.7592 56.7200 72.1300 54.1500 65.5000 16.49%
2011 51.0656 47.8200 56.3300 45.1600 56.2300 17.37%
2010 50.7320 54.4600 56.2400 45.8600 47.9100 -11.26%
2009 48.4288 53.5600 57.2500 41.5200 53.9900 1.16%
2008 55.1625 55.8100 60.5000 49.4500 53.3700 -4.95%
2007 54.4193 48.9700 59.4300 48.9700 56.1500 15.27%
2006 45.0284 39.5500 49.4800 39.5500 48.7100 23.54%
2005 45.3700 46.6700 49.9900 37.6300 39.4300 -15.48%
2004 42.3562 46.7500 46.9900 38.3600 46.6500 0.11%
2003 41.2727 40.0500 47.1500 34.3800 46.6000 16.50%
2002 45.8684 55.8400 57.7000 31.0000 40.0000 -28.25%
2001 50.0663 48.1300 56.7700 42.0600 55.7500 15.09%
2000 41.6982 35.0000 55.7500 29.6300 48.4400 33.41%
1999 43.6333 48.7500 52.9400 33.3100 36.3100 -25.90%
1998 40.9077 33.7200 49.7500 33.3450 49.0000 49.62%
1997 30.8148 25.1900 34.3150 25.1900 32.7500 29.06%
1996 22.6483 20.8750 28.3750 19.3750 25.3750 21.91%
1995 19.2416 16.3150 22.3150 15.6250 20.8150 27.58%
1994 14.8357 14.4400 16.8150 13.0650 16.3150 10.12%
1993 13.4211 15.1900 15.1900 11.5000 14.8150 -2.47%
1992 15.3475 16.8125 17.0300 13.5000 15.1900 -11.78%
1991 13.0176 10.8125 17.2175 9.9375 17.2175 53.04%
1990 9.5320 8.6563 11.3750 7.8750 11.2500 32.35%
1989 7.3855 5.9688 8.7663 5.8288 8.5000 41.28%
1988 5.8545 6.0788 6.5000 5.3750 6.0163 -0.25%
1987 7.1870 5.9375 8.3600 5.3750 6.0313 5.74%
1986 5.4847 4.2500 6.7963 3.9844 5.7038 33.48%
1985 3.4075 2.5394 4.3831 2.5000 4.2731 63.76%
1984 2.6840 2.8750 3.0000 2.3750 2.6094 -7.73%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $151.168B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $151.583B 20.94
Stryker (SYK) United States $76.313B 25.66
Boston Scientific (BSX) United States $61.440B 29.00
Baxter (BAX) United States $42.463B 25.75
Essilor Luxottica (ESLOY) France $33.468B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.550B 19.17
Terumo (TRUMY) Japan $27.062B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.531B 0.00
Coloplast (CLPBY) Denmark $25.294B 39.03
ResMed (RMD) United States $21.653B 39.94
Smith & Nephew SNATS (SNN) United Kingdom $19.279B 0.00
Sunny Optical Technology (SNPTF) China $19.151B 0.00
Insulet (PODD) United States $11.373B 541.06
Bio-Rad Laboratories (BIO) United States $11.201B 53.76
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.203B 21.24
Perrigo (PRGO) Ireland $7.117B 13.27
Canopy Growth (CGC) Canada $6.501B 0.00
Haemonetics (HAE) United States $6.146B 41.53
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
NuVasive (NUVA) United States $3.890B 30.64
ICU Medical (ICUI) United States $3.830B 24.97
Neogen (NEOG) United States $3.545B 59.33
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.165B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.121B 0.00
Quidel (QDEL) United States $2.954B 28.04
Aurora Cannabis (ACB) Canada $2.648B 0.00
National Vision Holdings (EYE) United States $2.432B 54.89
Agios Pharmaceuticals (AGIO) United States $2.411B 0.00
Cardiovascular Systems (CSII) United States $1.577B 0.00
InMode (INMD) Israel $1.516B 0.00
AtriCure (ATRC) United States $1.226B 0.00
Aphria (APHA) $1.187B 0.00
VAREX IMAGING (VREX) United States $1.162B 23.28
Phibro Animal Health (PAHC) United States $0.994B 18.61
NanoString Technologies (NSTG) United States $0.944B 0.00
Lantheus Holdings (LNTH) United States $0.802B 20.04
Eagle Pharmaceuticals (EGRX) United States $0.771B 29.55
TG Therapeutics (TGTX) United States $0.709B 0.00
Quanterix (QTRX) United States $0.705B 0.00
LeMaitre Vascular (LMAT) United States $0.698B 39.25
PetIQ (PETQ) United States $0.675B 16.46
Omeros (OMER) United States $0.655B 0.00
Cerus (CERS) United States $0.574B 0.00
Surmodics (SRDX) United States $0.570B 59.24
HEXO (HEXO) $0.537B 0.00
OraSure Technologies (OSUR) United States $0.492B 29.52
Owens & Minor (OMI) United States $0.474B 17.53
MacroGenics (MGNX) United States $0.474B 0.00
Organigram Holdings (OGI) Canada $0.405B 0.00
Utah Medical Products (UTMD) United States $0.396B 28.71
Meridian Bioscience (VIVO) United States $0.396B 13.62
BioLife Solutions (BLFS) United States $0.331B 134.92
Zynex (ZYXI) United States $0.329B 37.22
Bovie Medical (APYX) United States $0.275B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.269B 0.00
United Health Products (UEEC) United States $0.249B 0.00
Viemed Healthcare (VMD) United States $0.242B 25.52
Vapotherm (VAPO) United States $0.227B 0.00
Repro-Med Systems (KRMD) United States $0.195B 0.00
Liberty Health Sciences (LHSIF) Canada $0.192B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.164B 0.00
InfuSystems Holdings (INFU) United States $0.153B 773.00
Chimerix (CMRX) United States $0.151B 0.00
Female Health (VERU) United States $0.148B 0.00
Rockwell Medical (RMTI) United States $0.141B 0.00
Cytosorbents (CTSO) United States $0.128B 0.00
Fonar (FONR) United States $0.128B 9.03
MTech Acquisition (KERN) United States $0.114B 0.00
United-Guardian (UG) United States $0.091B 23.15
Oramed Pharmaceuticals (ORMP) United States $0.080B 0.00
Chembio Diagnostics (CEMI) United States $0.069B 0.00
Nephros (NEPH) United States $0.064B 0.00
Surface Oncology (SURF) United States $0.062B 0.00
MRI Interventions (MRIC) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.017B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00